Veeva Systems's ROE % for the quarter that ended in Apr. 2026 was 13.97%. Veeva Systems's PB Ratio for the quarter that ended in Apr. 2026 was 3.43.
Veeva Systems's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2026 was 4.07%.
Veeva Systems ROE % Adjusted to Book Value Related Terms
Veeva Systems ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Veeva Systems's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:V2EE34 vs BTSG, TEM, HQY: ROE % Adjusted to Book Value Comparison
For the Health Information Services subindustry, Veeva Systems's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Veeva Systems's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 4.07% mean?
Veeva Systems (BSP:V2EE34) has a ROE % Adjusted to Book Value of 4.07% as of Apr. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Veeva Systems and its competitors.
Is Veeva Systems' ROE % Adjusted to Book Value too high?
Veeva Systems' current ROE % Adjusted to Book Value is 4.07%. Overall, Veeva Systems has a GF Score™ of 97/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' ROE % Adjusted to Book Value compare to BTSG and TEM?
Veeva Systems' ROE % Adjusted to Book Value of 4.07% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Veeva Systems and its competitors. Veeva Systems's current ROE % Adjusted to Book Value is 4.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (BSP:V2EE34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$48.56, compared to a current price of R$32.73 — trading 32.6% below its estimated fair value. The current ROE % Adjusted to Book Value is 4.07%. Veeva Systems' overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Veeva Systems (BSP:V2EE34), the current ROE % Adjusted to Book Value is 4.07% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (BSP:V2EE34) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of R$32.73 is trading 32.6% below its estimated GF Value™ of R$48.56.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for BSP:V2EE34:
ROE % Adjusted to Book Value: 4.07%
GF Value™: R$48.56 vs. price of R$32.73 (32.6% below fair value)
No single metric tells the full story. See the BSP:V2EE34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
97GF Score
Get the complete analysis for BSP:V2EE34
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:V2EE34 has been successfully added to your 
